Additionally, thalidomide has promising therapeutic potential in tumor treatment, as shown by its ability to inhibit lung cancer cell invasion and metastasis, which involves the suppression of NF-κB-mediated ICAM-1 expression [450]. Here, NFKB1 is linked to neoplasm.